Should Biogen Buy Alkermes? Post author:Sam Post published:February 27, 2018 Post category:BioPharma After a huge dry spell in M&A, 2018 is shaping up to be a great year for deal making. Source: BioSpace You Might Also Like How Celgene Could Reap Huge Rewards From This Tiny Biotech November 16, 2017 FDA Advisory Panel Votes Against Approval Of Johnson & Johnson???s Sirukumab August 2, 2017 Investors Antsy as Novartis AG Mulls Over Selling $50 Billion in Assets May 29, 2017
